| Report ID |
103222 |
| Drug Identification Number |
02473968 |
| Brand name |
ODAN-SODIUM POLYSTYRENE SULFONATE |
| Common or Proper name |
Sodium Polystyrene Sulfonate Oral/Rectal Suspension |
| Company Name |
ODAN LABORATORIES LTD |
| Market Status |
MARKETED |
| Active Ingredient(s) |
SODIUM POLYSTYRENE SULFONATE |
| Strength(s) |
250MG |
| Dosage form(s) |
SUSPENSION |
| Route of administration |
ORAL
RECTAL |
| Packaging size |
60 mL |
| ATC code |
V03AE |
| ATC description |
ALL OTHER THERAPEUTIC PRODUCTS |
| Reason for shortage |
Other (Please describe in comments) |
| Anticipated start date |
2020-01-13 |
| Actual start date |
2020-01-13 |
| Estimated end date |
2022-01-30 |
| Actual end date |
2022-06-02 |
| Shortage status |
Resolved |
| Updated date |
2022-06-07 |
| Company comments |
Delay in testing of the drug |
| Health Canada comments |
|
| Tier 3 Status |
No |
| Company contact information |
info@odanlab.com
Tel.: 1-800-387-9342
Fax: 1-800-329-6326 |
